Serum asunaprevir concentrations showing correlation with the extent of liver fibrosis as a factor inducing liver injuries in patients with genotype-1b hepatitis C virus receiving daclatasvir plus asunaprevir therapy-Reference-Cited by-同舟云学术

Serum asunaprevir concentrations showing correlation with the extent of liver fibrosis as a factor inducing liver injuries in patients with genotype-1b hepatitis C virus receiving daclatasvir plus asunaprevir therapy

Published:2018-10-11 Issue:10 Volume:13 Page:e0205600
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Uchida Yoshihito,Naiki Kayoko,Kouyama Jun-ichi,Sugawara Kayoko,Nakao Masamitsu,Motoya Daisuke,Inao Mie,Nakayama Nobuaki,Imai Yukinori,Tomiya Tomoaki,Mochida Satoshi^ORCID

Funder

Bristol-Myers Squibb Canada

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference29 articles.

1. Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection;H Kumada;Hepatology,2014

2. A novel simple assay system to quantify the percent HCV-RNA levels of NS5A Y93H mutant strains and Y93 wild-type strains relative to the total HCV-RNA levels to determine the indication for antiviral therapy with NS5A inhibitors;Y Uchida;PLoS One,2014

3. Significance of variants associated with resistance to NS5A inhibitors in Japanese patients with genotype 1b hepatitis C virus infection as evaluated using cycling-probe real-time PCR combined with direct sequencing;Y Uchida;J Gastroenterol,2016

4. Development of rare resistance-associated variants that are extremely tolerant against NS5A inhibitors during daclatasvir/asunaprevir therapy by a two-hit mechanism;Y Uchida;Hepatol Res,2016

5. Randomized study of asunaprevir plus pegylated interferon-α and ribavirin for previously untreated genotype 1 chronic hepatitis C;JP Bronowicki;Antivir Ther,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of CYP3A5*3 genetic variant on the metabolism of direct-acting antivirals in vitro: a different effect on asunaprevir versus daclatasvir and beclabuvir;Journal of Human Genetics;2019-10-23

2. Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C;PLOS ONE;2019-07-10

3. Safety of Hepatitis C Viral Protease Inhibitors in Compensated Cirrhotics: Lingering Concerns Put to Rest?;Clinical Infectious Diseases;2019-03-28

4. Asunaprevir/daclatasvir;Reactions Weekly;2018-12